{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nBowman L. et al, (2022), Eur heart j
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNuffield Department of Population Health Renal Studies Group None. and SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium None., (2022), Lancet, 400, 1788 - 1801
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEMPA-KIDNEY Collaborative Group None. et al, (2022), N engl j med
\n \n \n \n\n \n
\n \n \n\n \n Preprint\n \n
\n \n\n \n \n \nHorby PW. et al, (2022)
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nStaplin N. et al, (2022), Hypertension
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMurray ML. et al, (2022), Lancet digit health, 4, e567 - e568
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPeto L. et al, (2022), Adv biol regul
\n \n \n \n\n \n
\n \n \n\n \n Other\n \n
\n \n\n \n \n \nHorby P. et al, (2022), Lancet, 399, 1776 - 1776
\n \n \n \n\n \n
\n \n \n\n \n Other\n \n
\n \n\n \n \n \nHorby P. et al, (2022), Lancet, 399, 1775 - 1776
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFraser AG. et al, (2022), European heart journal. quality of care & clinical outcomes, 8, 249 - 258
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLANDRAY M., (2022), Pilot and feasibility studies
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur heart j, 43, 1416 - 1424
\n \n \n \n\n \n
\n \n \n\n \n Preprint\n \n
\n \n\n \n \n \nHorby PW. et al, (2022)
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHERRINGTON W., (2022), Nephrology, dialysis and transplantation
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCake C. et al, (2022), Trials, 23
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHarper C. et al, (2021), Jama netw open, 4
\n \n \n \n\n \n
\n \n \n